amyloidosis therapy (orphanbiotec)

N/A

Report date: 2025/03/18 18:07:47
NME

Base Information

Drug Nameamyloidosis therapy (orphanbiotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmunoglobulin Light-chain Amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrphanbiotec Ag
China Registration ClassN/A

Develop Information

Active CompaniesOrphanbiotec Ag
Inactive CompaniesN/A
Active IndicationsImmunoglobulin Light-chain Amyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A